If you're interested in becoming a contributor or requesting changes then click here to join the discord
Difference between revisions of "Neuronetics"
Landonodnal (talk | contribs) |
Landonodnal (talk | contribs) |
||
| Line 17: | Line 17: | ||
[https://www.crunchbase.com/organization/neuronetics Crunchbase] | [https://www.crunchbase.com/organization/neuronetics Crunchbase] | ||
[https://www.linkedin.com/company/neuronetics-inc./ LinkedIn] | [https://www.linkedin.com/company/neuronetics-inc./ LinkedIn] | ||
| + | [https://twitter.com/tmstherapy Twitter][https://facebook.com/NeuroStarAdvancedTMS/ Facebook][https://instagram.com/NeuroStarAdvancedTMS/ Instagram] | ||
Revision as of 23:39, 21 March 2022
Neuronetics is a Malvern, PA based, publicly traded company incorporated in Delaware in April 2003, that develops non-invasive treatments for depression and other chronic psychiatric and neurological disorders based upon neuromodulation technology. Neuronetics became "the first company to get FDA authorization for a transcranial magnetic stimulation (TMS) device to treat major depressive disorder in 2008." They manufacture a transcranial magnetic stimulation device.
Founded in The United States around 2003, Neuronetics produces noninvasive hardware and end-user software.
Neuronetics makes tools for medical diagnosis and treatment through body/mind state interpretation and/or neurostimulation therapies.
BCI Categories: Open-Loop Afferent
Neurostimulation Technique(s): TMS
Links
Website Wikipedia Crunchbase LinkedIn TwitterFacebookInstagram